Submission Details
| 510(k) Number | K182779 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 01, 2018 |
| Decision Date | November 21, 2018 |
| Days to Decision | 51 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K182779 is an FDA 510(k) clearance for the ARK EDDP Assay, a Enzyme Immunoassay, Methadone (Class II — Special Controls, product code DJR), submitted by ARK Diagnostics, Inc. (Fremont, US). The FDA issued a Cleared decision on November 21, 2018, 51 days after receiving the submission on October 1, 2018. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3620.
| 510(k) Number | K182779 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 01, 2018 |
| Decision Date | November 21, 2018 |
| Days to Decision | 51 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | DJR — Enzyme Immunoassay, Methadone |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3620 |